Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.

× No keyword cloud information.

4 in total

1. The UK General Practice Research Database.

Authors: T Walley; A Mantgani
Journal: Lancet Date: 1997-10-11 Impact factor: 79.321

2. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports.

Authors: S J Evans; P C Waller; S Davis
Journal: Pharmacoepidemiol Drug Saf Date: 2001 Oct-Nov Impact factor: 2.890

Review 3. Primary chronic interstitial nephritis in Crohn's disease.

Authors: Hassane Izzedine; Jeanne Simon; Anne-Marie Piette; Michel Lucsko; Alain Baumelou; Didier Charitanski; Eve Kernaonet; Anne-Catherine Baglin; Gilbert Deray; Hélène Beaufils
Journal: Gastroenterology Date: 2002-11 Impact factor: 22.682

4. Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis.

Authors: R J Lancashire; K Cheng; M J S Langman
Journal: Aliment Pharmacol Ther Date: 2003-04-01 Impact factor: 8.171

4 in total

3 in total

1. Severe myalgia associated with mesalazine treatment in a child with Crohn's disease.

Authors: Mladen Persić; Goran Palcevski; Irena Slavić; Vera Vlahović-Palcevski
Journal: Eur J Clin Pharmacol Date: 2007-01-23 Impact factor: 2.953

Review 2. Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete?

Authors: A A van Bodegraven; Chris J J Mulder
Journal: World J Gastroenterol Date: 2006-10-14 Impact factor: 5.742

Review 3. Mild to moderate Crohn's disease: an evidence-based treatment algorithm.

Authors: Karen Wong; Brian Bressler
Journal: Drugs Date: 2008 Impact factor: 9.546

3 in total